biostudies-literatureBelghazi KBoston Scientific Corporation2864-2872https://www.ebi.ac.uk/biostudies/studies/S-EPMC6684496biostudies-literatureUnknown33(9)<h4>Background</h4>Multiband mucosectomy (MBM) is the preferred technique for piecemeal resection of early neoplastic lesions in Barrett's esophagus (BE). The currently most widely used device for MBM is the Duette device. Recently, the Captivator EMR device has come available which might have practical advantages over the Duette device.<h4>Methods</h4>Phase I was a randomized pre-esophagectomy trial with a non-inferiority design aiming to compare EMR specimens obtained with the Captivator and the Duette device.<h4>Primary outcome</h4>max diameter of the EMR specimens, secondary outcomes: min diameter, max thickness of the EMR specimens and resected submucosal stroma. Phase II were clinical pilot cases aiming to evaluate the feasibility of EMR using the Captivator device. Primary outcome wSurgical endoscopyResults of a two-phased clinical study evaluating a new multiband mucosectomy device for early Barrett's neoplasia: a randomized pre-esophagectomy trial and a pilot therapeutic pilot study.PMC6684496ISROTH50026Pouw REBelghazi KWeusten BLvan Berge Henegouwen MIScholvinck DWGisbertz SSMeijer SLBergman JJfalseResults of a two-phased clinical study evaluating a new multiband mucosectomy device for early Barrett's neoplasia: a randomized pre-esophagectomy trial and a pilot therapeutic pilot study.<h4>Background</h4>Multiband mucosectomy (MBM) is the preferred technique for piecemeal resection of early neoplastic lesions in Barrett's esophagus (BE). The currently most widely used device for MBM is the Duette device. Recently, the Captivator EMR device has come available which might have practical advantages over the Duette device.<h4>Methods</h4>Phase I was a randomized pre-esophagectomy trial with a non-inferiority design aiming to compare EMR specimens obtained with the Captivator and the Duette device.<h4>Primary outcome</h4>max diameter of the EMR specimens, secondary outcomes: min diameter, max thickness of the EMR specimens and resected submucosal stroma. Phase II were clinical pilot cases aiming to evaluate the feasibility of EMR using the Captivator device. Primary outcome w2019-01-01T00:00:00Z2019 Sep2025-04-26T11:36:09.365Z2019-08-23T07:03:11ZS-EPMC66844963045651110.1007/s00464-018-6582-5